Health
ACE2 agonist C21 relieves respiratory difficulty in COVID-19 – News-Medical.Net
A new study describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting enzyme 2 (ACE2), the host…
The advent of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 2.2 million deaths over a period of just over a year. The lack of effective drugs to combat the virus has led to intensive research to identify preventive and therapeutic antivirals.
A new preprint on the medRxiv* server describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting…
-
Noosa News23 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Noosa News22 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business14 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News14 hours agoRent changes on way for hundreds of social housing recipients following government review